Is Enzon Pharmaceuticals, stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Enzon Pharmaceuticals, pays dividends. Last time was Tuesday 15th of October 2019 where the investors holding the stock on Monday 30th of September 2019 were paid $0.12 per share. Over the last 10 times between 2012 and 2019, Enzon Pharmaceuticals, has paid $5.38 with an average of $0.54 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Enzon Pharmaceuticals, 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $0.255, you would have made a loss of $-0.105 per share or -41.18%
No, the average daily trading liquidity for Enzon Pharmaceuticals, is $21 809 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Enzon Pharmaceuticals, has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Enzon Pharmaceuticals, to be medium [0.6 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.